AMETEK (NYSE:AME) Receives Buy Rating from DA Davidson

DA Davidson restated their buy rating on shares of AMETEK (NYSE:AME) in a research note released on Wednesday,Benzinga reports. The firm currently has a $240.00 target price on the technology company’s stock.

Several other research firms also recently issued reports on AME. Weiss Ratings restated a “buy (b)” rating on shares of AMETEK in a report on Wednesday, January 21st. Mizuho set a $235.00 price target on shares of AMETEK in a research note on Wednesday. Barclays increased their price objective on shares of AMETEK from $210.00 to $220.00 and gave the company an “equal weight” rating in a research note on Wednesday. Royal Bank Of Canada reissued an “outperform” rating and issued a $257.00 target price on shares of AMETEK in a research report on Wednesday. Finally, Truist Financial set a $265.00 price target on shares of AMETEK in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $239.27.

AMETEK Price Performance

Shares of AME stock opened at $227.73 on Wednesday. The firm has a fifty day simple moving average of $209.65 and a 200-day simple moving average of $195.06. The company has a market capitalization of $52.42 billion, a PE ratio of 35.58, a price-to-earnings-growth ratio of 3.10 and a beta of 1.03. AMETEK has a twelve month low of $145.02 and a twelve month high of $234.56. The company has a current ratio of 1.06, a quick ratio of 0.72 and a debt-to-equity ratio of 0.10.

AMETEK (NYSE:AME) last issued its quarterly earnings data on Tuesday, February 3rd. The technology company reported $2.01 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.07. The firm had revenue of $2 billion for the quarter, compared to analyst estimates of $1.94 billion. AMETEK had a net margin of 20.00% and a return on equity of 16.55%. The firm’s revenue was up 13.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.87 EPS. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. Equities research analysts anticipate that AMETEK will post 7.15 earnings per share for the current fiscal year.

AMETEK Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Friday, December 5th were issued a $0.31 dividend. The ex-dividend date of this dividend was Friday, December 5th. This represents a $1.24 dividend on an annualized basis and a yield of 0.5%. AMETEK’s dividend payout ratio (DPR) is currently 19.56%.

Insider Buying and Selling at AMETEK

In other news, VP Thomas M. Montgomery sold 6,388 shares of AMETEK stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $205.05, for a total transaction of $1,309,859.40. Following the sale, the vice president owned 22,116 shares of the company’s stock, valued at approximately $4,534,885.80. The trade was a 22.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Thomas C. Marecic sold 14,310 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $202.11, for a total value of $2,892,194.10. Following the completion of the transaction, the insider directly owned 42,589 shares of the company’s stock, valued at $8,607,662.79. This trade represents a 25.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 137,088 shares of company stock worth $27,212,340 over the last ninety days. Company insiders own 0.57% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AME. Sivia Capital Partners LLC purchased a new position in shares of AMETEK in the second quarter worth approximately $295,000. Ameritas Advisory Services LLC purchased a new position in AMETEK during the 2nd quarter worth approximately $73,000. QRG Capital Management Inc. lifted its holdings in shares of AMETEK by 3.3% in the second quarter. QRG Capital Management Inc. now owns 6,889 shares of the technology company’s stock valued at $1,247,000 after purchasing an additional 219 shares in the last quarter. KLP Kapitalforvaltning AS boosted its position in shares of AMETEK by 0.7% in the second quarter. KLP Kapitalforvaltning AS now owns 81,238 shares of the technology company’s stock worth $14,701,000 after buying an additional 600 shares during the period. Finally, WoodTrust Financial Corp raised its position in AMETEK by 93.5% during the second quarter. WoodTrust Financial Corp now owns 22,911 shares of the technology company’s stock valued at $4,146,000 after buying an additional 11,068 shares during the period. Institutional investors own 87.43% of the company’s stock.

AMETEK News Summary

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: AMETEK reported record fourth-quarter and full-year 2025 results, with revenue up ~13.4% Y/Y and EPS beating consensus ($2.01 vs. $1.94). Strong top‑line growth and margin resilience underpin the bull case. AMETEK Announces Record Fourth Quarter and Full Year Results
• Positive Sentiment: Analysts reacted with some upgrades: KeyCorp raised its price target to $260 (overweight) and DA Davidson reaffirmed a Buy at $240 — both signal upside from current levels and support the stock. Benzinga
• Positive Sentiment: AMETEK announced the acquisition of LKC Technologies (ophthalmic diagnostics), adding a niche healthcare/medical device asset that diversifies revenue and enhances long‑term growth optionality. AMETEK Acquires LKC Technologies
• Neutral Sentiment: The company hosted an earnings call and published transcripts; management reiterated a confident long‑term outlook while discussing drivers behind the record results — useful for modeling but not market‑moving by itself. Earnings Call Transcript
• Neutral Sentiment: Coverage summaries and earnings recaps (Zacks, Globe and Mail, Seeking Alpha transcripts) confirm beats on EPS and revenue and provide detail for financial models. Zacks: AMETEK Q4 Earnings Surpass Expectations
• Negative Sentiment: FY‑2026 guidance came in slightly below Street expectations for EPS (7.870–8.070 vs. ~8.00 consensus) and Q1 guidance was marginally light — this tempered enthusiasm after the beat. MarketBeat: AMETEK Earnings
• Negative Sentiment: Management flagged tariff uncertainty and margin pressure in pockets of the business; analysts and commentary note acquisitions and niche expansion helped offset margin headwinds but risks remain. MSN: Q4 Deep Dive
• Negative Sentiment: Some analysts remain cautious on valuation — Morgan Stanley maintained a Hold with a $215 target and independent commentary warns that high valuation could lead to downgrades if execution slips. That contributes to short‑term selling pressure. TipRanks: Hold Rating

AMETEK Company Profile

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.